News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Local

CWLP Mulls $12 Monthly Increase for Residential Electric Customers

cwlp

Customer charges would go up, but electricity rates would go down in 2015.

in Local

Southeast Student Faces Weapons Charges as Juvenile

gun

A student accused of bringing an unloaded gun to school on Friday has been charged as a juvenile.

in Local

Competing Springfield Outlet Mall Proprietors Join Forces

legacy_pointe

Two competing interests both looking to build outlet malls have reportedly joined forces.

in Local

North Mac Intermediate School Closed Again Wednesday

carbon_monoxide

The district recreated the carbon monoxide leak that sent nearly 150 people to area hospitals

in Election 2014, Local

Rauner: Medical Marijuana Program “Ripe for Corruption”

marijuana

Bruce Rauner wants the application process changed for companies vying for dispensary and cultivator licenses.